AAWH Sales Down 10%
Ascend Wellness (OTC:AAWH), a multistate cannabis operator with a focus on both retail stores and vertically-integrated branded products, released its Q2 2025 results (reported in accordance with U.S. GAAP) on August 7, 2025. The company reported a GAAP net loss per share of ($0.12), while GAAP revenue came in at $127.3 million, slightly below the $128.3 million GAAP consensus forecast. Year over year, GAAP revenue dropped 10.0%. Adjusted EBITDA rose to $28.6 million, giving an Adjusted EBITDA margin of 22.4%. The period highlighted operational achievements in store expansion, product launches, and cash flow generation. However, Persistent pricing pressure, stagnant revenue, and rising net losses underscored the challenging industry environment for cannabis operators.
Source: Analyst estimates provided by FactSet. Management expectations based on management's guidance, as provided in Q1 2025 earnings report.
Ascend Wellness operates cannabis dispensaries and manufacturing facilities across seven states: Illinois, Maryland, Massachusetts, Michigan, New Jersey, Ohio, and Pennsylvania. It pursues a vertically-integrated model, meaning it handles cultivation, manufacturing, and retail delivery under its own brands. Its products include cannabis flower, pre-rolls, concentrates (extracts and oils), vapes, and edibles.
Source Fool.com
